Kalorama Information
Report suggests critical care pharmaceuticals market peaks at $1.7 billion
Published in Drug Law Weekly, June 27th, 2006
Cost-containment efforts, including the increased substitution of generics for brand drugs, could actually cause a decline in the market, as critical care units do their part to curb overall hospital expenditures. Indeed, factors affecting the markets for pharmaceuticals in the critical care setting are complex, as elements of both cost containment and the ability to most effectively treat ICU...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2006-06-27)
More Articles from Drug Law Weekly
- Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals adds three industry veterans - Chimerix, Inc.
Chimerix acquires compound library of antiviral agents from University of Michigan - Federal University of Minas Gerais, Brazil
Researchers' work from Brazil, the United States and Mexico adds to obesity body of knowledge - HIV/AIDS
Studies from the United States and Brazil add new findings to HIV/AIDS body of knowledge - Healthcare Access
Government forcing another tough choice in picking long-term care plan - Netherlands Cancer Institute, Netherlands
Recent studies from Netherlands, Greece and United States add new data to breast cancer research - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
